This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Idorsia Pharmaceuticals Ltd. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: Shuguang Yuan: Innovator in Pharmaceutical Modulation
Introduction
Shuguang Yuan is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of receptor modulators. With a total of 2 patents to his name, Yuan's work is recognized for its potential impact on medical treatments.
Latest Patents
Yuan's latest patents focus on piperidine derivatives that serve as CXCR7 receptor modulators. The inventions detail the preparation of these compounds, their pharmaceutically acceptable salts, and their applications in pharmaceutical compositions. These innovations are crucial for advancing therapeutic options in various medical conditions.
Career Highlights
Shuguang Yuan is currently employed at Idorsia Pharmaceuticals Ltd., where he continues to push the boundaries of pharmaceutical research. His work is characterized by a commitment to developing effective treatments that can improve patient outcomes.
Collaborations
Yuan collaborates with esteemed colleagues such as Hamed Aissaoui and Philippe Guerry. Their combined expertise fosters a productive environment for innovation and research.
Conclusion
Shuguang Yuan's contributions to pharmaceutical science through his patents and collaborations highlight his role as a key innovator in the field. His work on piperidine derivatives exemplifies the potential for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile